Konstantinos Vlassis appointed as Closed Loop Medicine’s chief technology officer
Closed Loop Medicine has announced the appointment of Konstantinos Vlassis as chief technology officer (CTO).
Vlassis brings with him extensive experience in designing and implementing technology strategies to support product delivery, and will oversee the company’s management of its technology platforms as well as being responsible for the company’s engineering, information security and technology infrastructure.
Vlassis has over 20 years of experience in the area, and will play a pivotal role in leading Closed Loop Medicine’s engineering team while facilitating cross-functional collaboration.
Previously, Vlassis worked as CTO at Medis Medical Imaging, and prior to this he was interim CTO at Winnow Systems Ltd.
Commenting on his appointment, Konstantinos Vlassis stated: “I am thrilled to be joining Closed Loop Medicine and becoming an integral part of the development of our technology platform and overall software engineering, information security and infrastructure to support bringing these life-changing products to the market. I am excited to work closely with the product, regulatory and operational teams to leverage the capabilities of our groundbreaking technologies that have the potential to revolutionise disease management and improve health outcomes for millions of patients.”
Dr Hakim Yadi OBE, CEO and co-founder of Closed Loop Medicine, added: “It has been a pivotal year for the company’s growth, particularly to establish strategic collaborations and strengthen our senior leadership team. As chief technology officer, Konstantinos brings a wealth of experience in designing and implementing productive, transparent, accountable technology strategies within strict regulatory constraints and delivering innovative products. As we continue to develop our dose optimisation combination products enabling bespoke treatment decisions at an individual patient level, the expertise Konstantinos brings to the team is invaluable and I’m delighted to welcome him to the team.”
Pharmaceutical Industry news, analysis and insights